FMR LLC 13D and 13G filings for Tango Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-06 11:14 am Sale | 2024-11-29 | 13G | Tango Therapeutics, Inc. TNGX | FMR LLC | 13,392 0.000% | -9,773,958 (-99.86%) | Filing |
| 2024-02-09 09:49 am Sale | 2024-02-08 | 13G | Tango Therapeutics, Inc. TNGX | FMR LLC | 9,787,350 9.596% | -3,760,722 (-27.76%) | Filing |
| 2023-09-11 08:23 am Purchase | 2023-09-08 | 13G | Tango Therapeutics, Inc. TNGX | FMR LLC | 13,548,072 13.326% | 4,464,393 (+49.15%) | Filing |
| 2023-02-09 12:39 pm Purchase | 2023-02-09 | 13G | Tango Therapeutics, Inc. TNGX | FMR LLC | 9,083,679 8.291% | 1,901,491 (+26.48%) | Filing |
| 2022-02-09 10:01 am Purchase | 2022-02-08 | 13G | Tango Therapeutics, Inc. TNGX | FMR LLC | 7,182,188 6.593% | 7,182,188 (New Position) | Filing |